Clean water is one of the few things in life that never fails to live up to expectations.
It is difficult to overstate the importance of having it. Really difficult. In fact, it's probably impossible. Clean water changes almost everything.
Let's start with the obvious things. Having clean water and sanitation means being able to avoid exposure to countless diseases. Every year millions of people die from diseases caused by inadequate water supply, sanitation and hygiene.
Did you know of 7,000 rare diseases, only 5% have treatments available?
On July 18th, Shire invited professionals local to Cambridge, MA to participate in Rare in Kendall Square: Collaborating to Advance Innovation in Rare Disease. Over 200 attendees gathered to network and weigh in on a panel discussion centered around the idea that partnerships can advance treatment options.
“Our fight against rare diseases cannot be waged alone – unique partnership models are critical,” said Flemming Ornskov, M.D., M.P.H. and CEO of Shire.
Originally published in Best Practice - Spring 2017 issue
Pfizer believes its business and societal missions are the same: to ensure that all individuals everywhere have access to quality medicines, vaccines and healthcare, and the opportunity to lead healthy lives. Every day, the company strives to use its full resources – people, products and funding – to find new ways to positively impact the health of people around the world.
Subaru of America aims to spread some extra love, hope, and warmth in the month of June by coming together with The Leukemia & Lymphoma Society (LLS) to reach out to cancer patients across the country. This is the second year in a row that Subaru has chosen to team up with LLS as a charity partner. Last year, the 2016 Subaru Loves to Care initiative was able to reach 30,00
Subaru of America will partner with the Leukemia and Lymphoma Society to help people affected by cancer as part of the carmaker's annual Subaru Loves to Care month. Subaru will be working with the organization to spread awareness of the disease, and raise money for cancer survivors.
Following the G20, Joerg Reinhardt, Chairman of the Novartis Board of Directors, reflects on how to fight rising antimicrobial resistance
ZURICH, Switzerland, July 20, 2017/3BL Media/ – Two weeks ago, G20 leaders committed to working together to address one of the world’s most pressing and perplexing security threats: antimicrobial resistance (AMR) – a fierce and evolving adversary against which conventional therapeutic weapons are of no use.
“MTV Shuga” returns to Nigeria for its 6th and 7th seasons with focus on family planning and contraception
LONDON, July 19, 2017 /3BL Media/ - Today at the Family Planning 2020 summit in London, Viacom International Media Networks (VIMN) announced it plans to expand MTV Shuga, the award-winning drama series from MTV International and MTV Staying Alive Foundation, with two new localized versions in India and Egypt by 2020. The new campaign in India will mark the first time the series has been created for a region outside of Sub-Saharan Africa. Additionally, the show will return to Nigeria for two additional seasons
Team members raise $110,000; locations serve as event pit stops in fifth consecutive year as sponsor
ATLANTA, July 13, 2017 /3BL Media/ - Manheim team members nationwide rallied to support the 23rd anniversary Kyle Petty Charity Ride Across America May 13-19, 2017. For the fifth consecutive year, the brand was a presenting sponsor, raising a record-breaking $110,000 to support the Ride’s primary benefactor, Victory Junction, a camp dedicated to providing life-changing experiences to children with chronic or life-threatening illnesses.
In two articles in the Lancet Infectious Diseases, the Novartis Foundation and its partners review the historic and future innovations and game-changing strategies in leprosy elimination, calling for a global effort to make leprosy history.
July 10, 2017 /3BL Media/ - On July 7th, 2017 the Novartis Foundation and its partners published two articles that call for a global effort to make leprosy history. The reviews have been published in the Lancet Infectious Diseases, a leading journal in infectious diseases.[i]
Novartis reaches agreement with Uganda to supply medicines that address the rapid rise of chronic diseases in the country. Uganda becomes the fifth country to launch the Novartis Access program.
July 6, 2017 /3BL Media/ -- We are pleased to announce that Novartis and the Ministry of Health of Uganda have signed a Memorandum of Understanding to implement Novartis Access in Uganda. Novartis Access medicines will be made available to patients in public health facilities through the National Medical Stores and through faith-based health services. The program will also cover capacity-building activities, including NCD prevention, diagnosis and treatment.